DK1392670T3 - Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater - Google Patents

Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater

Info

Publication number: DK1392670T3
Authority: DK; Denmark
Prior art keywords: methylamine; thiophen; furan; substituted; derivatives
Prior art date: 2001-05-22

Application number

DK02743057T

Other languages

English (en)

Inventor

Corinna Maul

Michael Przewosny

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-22

Filing date

2002-05-21

Publication date

2005-08-08

2002-05-21 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2005-08-08 Application granted granted Critical

2005-08-08 Publication of DK1392670T3 publication Critical patent/DK1392670T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)

DK02743057T 2001-05-22 2002-05-21 Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater DK1392670T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10125145A DE10125145A1 (de)	2001-05-22	2001-05-22	Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate
PCT/EP2002/005542 WO2002094802A1 (de)	2001-05-22	2002-05-21	Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate

Publications (1)

Publication Number	Publication Date
DK1392670T3 true DK1392670T3 (da)	2005-08-08

Family

ID=7685874

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02743057T DK1392670T3 (da)	2001-05-22	2002-05-21	Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater

Country Status (17)

Country	Link
US (2)	US6878740B2 (da)
EP (1)	EP1392670B1 (da)
JP (1)	JP2004532246A (da)
AR (1)	AR035982A1 (da)
AT (1)	ATE299873T1 (da)
AU (1)	AU2002338989B2 (da)
CA (1)	CA2448038C (da)
DE (2)	DE10125145A1 (da)
DK (1)	DK1392670T3 (da)
ES (1)	ES2242869T3 (da)
HU (1)	HUP0401162A3 (da)
MX (1)	MXPA03010601A (da)
PE (1)	PE20021099A1 (da)
PL (1)	PL367535A1 (da)
PT (1)	PT1392670E (da)
SI (1)	SI1392670T1 (da)
WO (1)	WO2002094802A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0302094D0 (en) *	2003-01-29	2003-02-26	Pharmagene Lab Ltd	EP4 receptor antagonists
GB0324269D0 (en) *	2003-10-16	2003-11-19	Pharmagene Lab Ltd	EP4 receptor antagonists
KR100553398B1 (ko) *	2004-03-12	2006-02-16	한미약품 주식회사	티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
SG176983A1 (en)	2009-07-08	2012-02-28	Dermira Canada Inc	Tofa analogs useful in treating dermatological disorders or conditions
TR201802607T4 (tr) *	2013-11-22	2018-03-21	Teva Branded Pharmaceutical Prod R & D Inc	Bir solunabilir ilaç.
CN109153659A (zh) *	2016-05-31	2019-01-04	翰林大学产学研合作团队	五元杂环衍生物、其制备方法及包含其的药剂学组合物
CN112521357B (zh) *	2020-08-31	2021-10-08	深圳瑞健生物科技有限公司	一种长效低成瘾性hnk衍生物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3890445A (en) *	1973-01-05	1975-06-17	Richardson Merrell Inc	Lactamimide derivatives useful as hypoglycemic agents
US3816457A (en) *	1973-01-05	1974-06-11	Richardson Merrell Inc	Lactamimide derivatives
WO2001068816A1 (en)	2000-03-13	2001-09-20	Smithkline Beecham Corporation	Human histamine h3 gene variant-3
DE10012820A1 (de) *	2000-03-16	2001-09-20	Bayer Ag	Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine
DE10059864A1 (de) *	2000-11-30	2002-06-13	Gruenenthal Gmbh	Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate

2001
- 2001-05-22 DE DE10125145A patent/DE10125145A1/de not_active Withdrawn
2002
- 2002-05-17 AR ARP020101843A patent/AR035982A1/es not_active Application Discontinuation
- 2002-05-21 AT AT02743057T patent/ATE299873T1/de not_active IP Right Cessation
- 2002-05-21 ES ES02743057T patent/ES2242869T3/es not_active Expired - Lifetime
- 2002-05-21 EP EP02743057A patent/EP1392670B1/de not_active Expired - Lifetime
- 2002-05-21 PT PT02743057T patent/PT1392670E/pt unknown
- 2002-05-21 WO PCT/EP2002/005542 patent/WO2002094802A1/de active IP Right Grant
- 2002-05-21 HU HU0401162A patent/HUP0401162A3/hu unknown
- 2002-05-21 PE PE2002000428A patent/PE20021099A1/es not_active Application Discontinuation
- 2002-05-21 JP JP2002591475A patent/JP2004532246A/ja active Pending
- 2002-05-21 PL PL02367535A patent/PL367535A1/xx not_active Application Discontinuation
- 2002-05-21 AU AU2002338989A patent/AU2002338989B2/en not_active Ceased
- 2002-05-21 MX MXPA03010601A patent/MXPA03010601A/es active IP Right Grant
- 2002-05-21 SI SI200230178T patent/SI1392670T1/sl unknown
- 2002-05-21 CA CA2448038A patent/CA2448038C/en not_active Expired - Fee Related
- 2002-05-21 DK DK02743057T patent/DK1392670T3/da active
- 2002-05-21 DE DE50203686T patent/DE50203686D1/de not_active Expired - Lifetime
2003
- 2003-11-21 US US10/717,932 patent/US6878740B2/en not_active Expired - Fee Related
2005
- 2005-03-07 US US11/072,962 patent/US7317034B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2004532246A (ja)	2004-10-21
DE10125145A1 (de)	2002-11-28
US20040152734A1 (en)	2004-08-05
US20050148550A1 (en)	2005-07-07
SI1392670T1 (sl)	2005-12-31
US7317034B2 (en)	2008-01-08
DE50203686D1 (en)	2005-08-25
PL367535A1 (en)	2005-02-21
CA2448038C (en)	2010-09-28
ATE299873T1 (de)	2005-08-15
EP1392670B1 (de)	2005-07-20
EP1392670A1 (de)	2004-03-03
MXPA03010601A (es)	2004-03-09
HUP0401162A2 (hu)	2004-10-28
AU2002338989B2 (en)	2007-06-07
WO2002094802A1 (de)	2002-11-28
AR035982A1 (es)	2004-07-28
PT1392670E (pt)	2005-10-31
US6878740B2 (en)	2005-04-12
ES2242869T3 (es)	2005-11-16
CA2448038A1 (en)	2002-11-28
PE20021099A1 (es)	2003-01-25
HUP0401162A3 (en)	2007-05-02

Publication	Publication Date	Title
ATE319451T1 (de)	2006-03-15	Tetrahydrochinolin-derivate
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
NO20041975L (no)	2005-07-16	Bicyklisk oksopyridin og oksopyrimidinderivater
DE60238204D1 (de)	2010-12-16	Aufzeit
PT1411764E (pt)	2005-05-31	Cerca
ATE288437T1 (de)	2005-02-15	Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
EE200300447A (et)	2003-12-15	Asendatud bensofuraan-2-karboksamiidide derivaadid
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
DE60135230D1 (de)	2008-09-18	Aminocyclohexan-derivate
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
DK1246791T3 (da)	2005-02-14	Aminomethyl-phenyl-cyklohexanonderivater
DK1392670T3 (da)	2005-08-08	Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
DE60117096D1 (de)	2006-04-20	Dihydroindol- und tetrahydrochinolinderivate
ATE382601T1 (de)	2008-01-15	Substituierte 4-aminocyclohexanolderivate
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE60219418D1 (de)	2007-05-24	Silanylphenole und -naphthole
DE50209548D1 (de)	2007-04-05	Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater